drugset / Trial / NCT06316908

Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach

NCT06316908

Phase 4 Completed 30 enrolled Sindh Institute of Urology and Transplantation
Non-randomizedParallel-groupOpen-labelSupportive care

Summary

The goal of this prospective, interventional, non-randomized study was to compare pain score in unilateral and bilateral posterior percutaneous neurolytic celiac plexus block (NCPB) in upper abdominal cancer patients. The main questions it aimed to answer are: 1. Whether unilateral or bilateral NCPB technique has a better pain relief 2. Was there any difference in terms of complication rates between these two approaches All participants were having upper abdominal cancer whether operated or non-operable cancer were given a unilateral or bilateral neurolytic celiac plexus block. Pain scores and adverse events at multiple time points post-procedure were recorded.

Timeline

Start
2020-02-25
Primary completion
2022-07-15
Completion
2023-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Absolute Alcohol Unknown 20 ml Other
Comparator Absolute Alcohol Unknown 40 ml Other